Загрузка...
A Real Life Experience with the Comsos Regimen in Genotype 1 Chronic Hepatitis C Treatment: Including Patients with East Asian Ancestry and Decompensated Cirrhosis
BACKGROUND/AIMS: The COMSOS phase 2 trial showed high cure rates and a favorable side effect profile of a 12-week regimen of Sofosbuvir (SOF) and Simeprevir (SIM) in patients with a genotype 1 Hepatitis C infection. However, given the small number of patients in the COSMOS trial, there is uncertaint...
Сохранить в:
| Опубликовано в: : | Hawaii J Med Public Health |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
University Clinical, Education & Research Associate (UCERA)
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582373/ |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|